Vani Commercials Receives BSE Trading Approval for 17,666,663 Preferential Equity Shares

Vani Commercials Limited has secured trading approval from BSE Limited for 17,666,663 equity shares issued on a preferential basis to non-promoters. The development was disclosed pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, with the company's Managing Director, Vishal Abrol, signing off on the regulatory filing dated May 11, 2026.

Trading Approval Details

The BSE communicated its approval through letter no. LOD/PREF/SV/148/2026-27, confirming that the newly issued equity shares are listed on the Exchange effective Tuesday, May 12, 2026. The key parameters of the approved securities are outlined below:

Parameter: Details Number of Shares: 17,666,663 Face Value: ₹10.00/- per share Premium: ₹2.00/- per share Distinctive Numbers: 11740621 to 29407283 Allotment Type: Preferential basis to Non-Promoters Trading Effective From: Tuesday, May 12, 2026 BSE Letter Reference: LOD/PREF/SV/148/2026-27 BSE Notice No.: 20260511-10 dated May 11, 2026

Regulatory Compliance

The announcement was made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Vani Commercials noted that a copy of the trading approval received from BSE Limited has been attached as Annexure-A to the regulatory filing. Trading members of the Exchange were separately notified via BSE Notice No. 20260511-10 dated May 11, 2026, available on the BSE website.

The filing was signed by Vishal Abrol, Managing Director (DIN: 06938389), on behalf of Vani Commercials Limited. The BSE approval letter was jointly signed by Marian Dsouza, Assistant Vice President, and Karan Shah, Deputy Manager, from the Exchange's side.

Vani Commercials Limited has announced receiving listing approval from BSE Limited for a substantial equity share issuance. The company informed the exchange about this significant corporate development under regulatory compliance requirements on April 24, 2026.

Listing Approval Details

BSE Limited has granted listing approval for the company's preferential share issue through its letter no. LOD/PREF/KS/FIP/129/2026-27 dated April 23, 2026. The approval covers specific parameters for the equity shares issued to non-promoters.

Parameter: Details Total Shares Approved: 1,76,66,663 equity shares Face Value: Rs. 10/- each Premium: Rs. 2/- each Issue Type: Preferential basis to non-promoters Distinctive Numbers: 11740621 to 29407283 BSE Letter Reference: LOD/PREF/KS/FIP/129/2026-27

Regulatory Compliance Requirements

BSE has outlined several compliance requirements that the company must fulfill. The exchange emphasized adherence to Regulation 167 of SEBI (ICDR) Regulations and other specifications mandated by SEBI from time to time.

The company must file shareholding patterns in XBRL mode as required under Regulations 31(1)(c) of SEBI LODR Regulations, 2015, particularly if there is a change exceeding two percent of the total paid-up share capital.

Trading Approval Prerequisites

BSE has specified that trading approval for the mentioned shares will be granted only after the company files specific documents with the exchange:

Listing approval from National Stock Exchange of India Ltd. (if applicable)

Confirmation letters from NSDL/CDSL about crediting shares to respective beneficiary accounts

Confirmation about admitting the capital to the depository system

Confirmation letters regarding lock-in of pre-preferential holding (if applicable)

Timeline and Compliance Obligations

According to Schedule XIX of ICDR Regulations and SEBI circular SEBI/HO/CFD/PoD-2/P/CIR/2023/00094 dated June 21, 2023, listed entities must make an application for trading approval to stock exchanges within seven working days from the date of grant of listing approval. Non-compliance with this requirement will attract fines as mentioned in the referenced SEBI circular.

Corporate Announcement

The announcement was made by Managing Director Vishal Abrol (DIN: 06938389) on April 24, 2026, pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has provided the BSE listing approval letter as supporting documentation for this regulatory disclosure.

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.

We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.

This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.

The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.

We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.

This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.

By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.

We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.